Clinical Trials

3,708 enrolled

Treatment of Venous Thromboembolism in Cancer Patients

NCT03433560 2024-05-14

An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)

1,300 enrolled

Neutropenia, Febrile Neutropenia

NCT01931644 2024-04-18

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

BreastClassical hematologyDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmPlasma cellThoracic

17,667 enrolled

Generalized Anxiety Disorder, Acquired Immunodeficiency Syndrome, Alopecia Areata, Anemia, Sickle Cell, Asthma, Bipolar Disorder, Breast Neoplasms, Celiac Disease, Uterine Cervical Neoplasms, Colitis, Ulcerative, Colonic Neoplasms, Crohn Disease, Cystic Fibrosis, Depression, Diabetes Mellitus, Down Syndrome, Endometriosis, Epilepsy, Glucosephosphate Dehydrogenase Deficiency, Hepatitis B, Huntington Disease, Sleep Initiation and Maintenance Disorders, Kidney Neoplasms, Polycystic Kidney Diseases, Leukemia, Lung Neoplasms, Lupus Erythematosus, Systemic, Lupus Nephritis, Lymphoma, Melanoma, Multiple Myeloma, Multiple Sclerosis, Muscular Atrophy, Spinal, Myositis, Myotonic Dystrophy, Ovarian Neoplasms, Pancreatic Neoplasms, Parkinson Disease, Prostatic Neoplasms, Psoriasis, Purpura, Thrombotic Thrombocytopenic, Rosacea, Sickle Cell Trait, Sjogren's Syndrome, Skin Neoplasms, Spondylitis, Ankylosing, Telangiectasia, Hereditary Hemorrhagic, Colorectal Neoplasms, Arthritis, Psoriatic, Purpura, Thrombocytopenic, Idiopathic, beta-Thalassemia, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Muscular Dystrophy, Duchenne, Muscular Dystrophy, Facioscapulohumeral, Pulmonary Disease, Chronic Obstructive, Scleroderma, Diffuse, Renal Insufficiency, Chronic

NCT00516373 2024-02-22

A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP)

Phase 1 Completed

98 enrolled

Classical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

NCT00494234 2024-01-19

ICEBERG 1

BreastClassical hematology

54 enrolled 17 charts

Fanconi Anemia, Complementation Group D1, Breast Neoplasms

NCT05150938 2023-12-18

A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

5,737 enrolled

Treatment of Venous Thromboembolism in Cancer Patients

NCT02503436 2023-12-04

C-PATROL

Classical hematologyGynecologic

276 enrolled

Fanconi Anemia, Complementation Group D1, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03471078 2023-09-28

Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

122 enrolled 19 charts

Thrombocytopenia

NCT03194542 2023-08-24

A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence

Classical hematologyMyeloid

95 enrolled 32 charts

Anemia, Primary Myelofibrosis

NCT03104595 2023-08-15

Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer

Phase 1/2 Completed

28 enrolled

BreastClassical hematology

Breast Neoplasms, Febrile Neutropenia

NCT01583218 2023-08-07

APEX

7,513 enrolled 18 charts 2 FDA

Venous Thromboembolism

NCT03036813 2023-07-27

GBT_HOPE

449 enrolled 17 charts 2 FDA

Anemia, Sickle Cell

NCT04318405 2023-07-19

Real-CHOICE

327 enrolled

Classical hematologySarcomaThoracic

Anemia, Iron-Deficiency

NCT02797977 2023-06-22

A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects

Phase 1/2 Completed

153 enrolled

Fanconi Anemia, Sarcoma, Small Cell Lung Carcinoma

NCT02797964 2023-06-18

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Phase 1/2 Completed

107 enrolled 20 charts

Classical hematologyGastrointestinalHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Fanconi Anemia, Lymphoma, Non-Hodgkin, Colorectal Neoplasms

NCT05301517 2023-06-06

A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies

159 enrolled

Chemotherapy Induced Anemia

NCT04939558 2023-06-02

CARES

Classical hematologyThoracic

744 enrolled

Post-Acute COVID-19 Syndrome, Anemia, Asthma, Bronchiectasis, Heart Failure, Lung Neoplasms, Respiration Disorders, Lung Diseases, Interstitial, Pulmonary Disease, Chronic Obstructive

NCT05112666 2023-04-03

A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)

2,601 enrolled

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Treatment of Venous Thromboembolism in Cancer Patients

NCT03886831 2023-03-28

A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies

Phase 1 Completed

232 enrolled

Anemia, Refractory, with Excess of Blasts, Carcinoma, Adenoid Cystic, Recurrence, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Primary Myelofibrosis

NCT03020160 2023-01-11

HAVEN 4

48 enrolled 44 charts 2 FDA

Classical hematologyMyeloidOther hematologic neoplasm

Hemophilia A

NCT01957176 2022-12-30

A Rollover Study to Provide Continued Treatment With Eltrombopag

Phase 4 Completed

22 enrolled 9 charts

Myelodysplastic Syndromes, Thrombocytopenia, Leukemia, Myeloid, Acute, Purpura, Thrombocytopenic, Idiopathic

NCT02847637 2022-11-16

HAVEN 3

152 enrolled 46 charts 2 FDA

Hemophilia A

NCT05461807 2022-10-26

H2H-OSCAR-US

2,437 enrolled

Neoplasms, Venous Thromboembolism

NCT01736683 2022-10-24

Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)

Classical hematologyMyeloidOther hematologic neoplasm

74 enrolled 33 charts

Anemia, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT02921802 2022-06-14

A Study of Special Use Results Surveillance of Revlimid 5mg Capsules

Classical hematologyMyeloidOtherPlasma cell

4,626 enrolled

Arrhythmias, Cardiac, Constipation, Diarrhea, Heart Failure, Hemorrhage, Hypersensitivity, Infections, Multiple Myeloma, Myelodysplastic Syndromes, Myocardial Infarction, Neutropenia, Peripheral Nervous System Diseases, Thrombocytopenia, Tumor Lysis Syndrome, Lung Diseases, Interstitial, Renal Insufficiency, Venous Thromboembolism, Teratogenesis

NCT02922543 2022-06-14

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

Classical hematologyOtherPlasma cell

361 enrolled

Arrhythmias, Cardiac, Constipation, Diarrhea, Heart Failure, Hemorrhage, Hypersensitivity, Infections, Multiple Myeloma, Myocardial Infarction, Neutropenia, Peripheral Nervous System Diseases, Thrombocytopenia, Tumor Lysis Syndrome, Lung Diseases, Interstitial, Renal Insufficiency, Venous Thromboembolism, Teratogenesis

NCT04076943 2022-06-03

Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia

92 enrolled 18 charts

Anemia

NCT02467868 2022-02-14

Efficacy and Safety Study With MYL-1401H and Neulasta

BreastClassical hematology

193 enrolled

Breast Neoplasms, Neutropenia, Chemotherapy-Induced Febrile Neutropenia

NCT04466137 2022-02-09

Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy

398 enrolled

Neutropenia, Febrile Neutropenia

NCT02631070 2021-12-17

MEDALIST

229 enrolled 36 charts 3 FDA

Classical hematologyMyeloid

Anemia, Myelodysplastic Syndromes

NCT04425200 2021-12-07

ZENSHIN

Classical hematologyGenitourinary

205 enrolled

Fanconi Anemia, Complementation Group D1, Hereditary Sensory and Autonomic Neuropathies, Prostatic Neoplasms

NCT03965741 2021-11-30

PRACTISE

97,765 enrolled

Venous Thromboembolism

NCT02622321 2021-06-24

HAVEN 1

113 enrolled 45 charts 2 FDA

Hemophilia A

NCT02795767 2021-06-02

HAVEN 2

88 enrolled 65 charts 2 FDA

Hemophilia A

NCT01663441 2020-09-16

A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11

62 enrolled

Thrombocytopenia

NCT01179217 2020-08-19

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

230 enrolled 19 charts 2 FDA

Vaso-Occlusive Crises, Anemia, Sickle Cell

NCT04460079 2020-07-07

Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN

654 enrolled

Febrile Neutropenia

NCT01241500 2020-06-30

ONTIME

Classical hematologyMyeloidOther hematologic neoplasm

299 enrolled

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT01928537 2020-06-30

Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine

Classical hematologyMyeloidOther hematologic neoplasm

67 enrolled

Cytopenia, Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT02516579 2020-03-19

ESCORT-HU

1,906 enrolled 9 charts 2 FDA

Anemia, Sickle Cell

NCT01895361 2020-01-31

SUSTAIN

198 enrolled 18 charts 2 FDA

Anemia, Sickle Cell, Priapism

NCT03099031 2019-12-16

PREDICARE

BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

420 enrolled

Breast Neoplasms, Digestive System Neoplasms, Intestinal Neoplasms, Leukemia, Lung Neoplasms, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Neoplasms, Prostatic Neoplasms, Thromboembolism, Urogenital Neoplasms, Vascular Diseases, Colorectal Neoplasms, Hemostatic Disorders, Venous Thrombosis, Venous Thromboembolism

NCT00628251 2019-12-05

ICEBERG 3

Classical hematologyGynecologic

97 enrolled 22 charts

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

NCT02555878 2019-09-12

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

841 enrolled 24 charts